Long-term effects of Acoltremon for dry eye disease
Treatments studied
Part of Eyes & vision clinical trials.
This study tests a new medication called Acoltremon to see if it helps dry eye symptoms over a long period. If you've had dry eye for a while and used artificial tears, this trial might be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been diagnosed with dry eye disease in the past 6 months.
- You have used or want to use artificial tears for your dry eye.
- You have at least a moderate amount of dry eye signs in one eye, like staining or low tear production.
- You have a dry eye symptom score of 40 or more out of 100.
- You are willing to stop using artificial tears for 24 hours before study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new eye drop called TRYPTYR to see if it can improve quality of life and daily tasks for people with dry eye disease who are unhappy with their current treatment, Restasis. Participants will stop using Restasis and switch to TRYPTYR for about 4 weeks.
This study tests if switching from Xiidra to another dry eye drop (TRYPTYR) works better for people with dry eye disease. You may qualify if Xiidra isn't helping enough and you've been using it for at least a month.
This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.
This study tests a new eye drop called Acoltremon to see if it can relieve symptoms of moderate-to-severe dry eye disease. It may be a good option if you have had dry eye for at least 6 months and use artificial tears.
This study tests an FDA-approved dry eye treatment called acoltremon. We want to see if it helps people with dry eye disease feel better. You will answer surveys about your symptoms.
This trial tests a new eye drop (acoltrepon) to see if it helps people with stage 1 neurotrophic keratopathy (a condition where the cornea's nerves are damaged, causing dry eyes and vision problems) and low tear production. It aims to improve signs like corneal staining and symptoms of discomfort.
Hear when a new Dry Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.